Jacobio Pharmaceuticals Group Co., Ltd.

HKEX:1167.HK

1.75 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -96.419-96.419-83.141-83.141-122.018-122.018-63.913-63.913-82.295-82.295-68.299-68.299-351.38-351.38-405.448-405.448-135.347-135.347-77.059-77.059
Depreciation & Amortization 7.5627.5624.9784.9783.6943.6943.2043.2042.9532.9532.4432.4431.7041.7042.4372.4372.5012.5014.0934.093
Deferred Income Tax 0000-21.83-44.7900000000000000
Stock Based Compensation 3.783.783.6493.6495.2535.2533.2443.2444.314.315.4155.4156.4256.4253.4033.40334.14534.1450.1770.177
Change In Working Capital 1.3111.3110043.41443.4140044.43644.43600-87.419-87.419001.231.23-0.69-0.69
Accounts Receivables 5.1895.1890039.53739.5370044.51644.51600-93.968-93.96800-0.589-0.589-0.272-0.272
Change In Inventory 00000000000000000000
Change In Accounts Payables 00000000000000000000
Other Working Capital -3.878-3.878003.8773.87700-0.08-0.08006.5496.549001.8181.818-0.418-0.418
Other Non Cash Items 11.54811.548-35.367-35.367-20.638-20.6381.5521.55214.22714.2273.0663.066506.084506.084363.607363.60764.02564.02550.41350.413
Operating Cash Flow -72.219-72.219-109.881-109.881-90.296-90.296-55.913-55.913-16.37-16.37-57.376-57.37675.41475.414-36.002-36.002-33.447-33.447-23.066-23.066
Investing Activities:
Investments In Property Plant And Equipment -1.727-1.727-17.188-17.188-6.819-6.819-1.403-1.403-1.363-1.363-3.691-3.691-4.695-4.695-0.374-0.374-0.807-0.807-0.864-0.864
Acquisitions Net 001.62900.048000000000000000
Purchases Of Investments 00-329.1370-742.914000000000000000
Sales Maturities Of Investments 00545.640-0.47000000000000000
Other Investing Activites -107.576-107.576102.49102.49-335.491-335.4910.5520.552-8.86-8.8694.74794.747-68.024-68.024-34.689-34.689107.937107.937-106.403-106.403
Investing Cash Flow -109.303-109.30385.30285.302-342.31-342.31-0.852-0.852-10.223-10.22391.05691.056-72.719-72.719-35.063-35.063107.13107.13-107.267-107.267
Financing Activities:
Debt Repayment 00-67.85700000000000000000
Common Stock Issued 00157.35700000000000000000
Common Stock Repurchased -2.841-2.841000000000000000000
Dividends Paid 00000000000000000000
Other Financing Activities 31.31531.31594.66594.665-3.416-3.416-1.511-1.511-5.293-5.29359.82159.821556.32556.3281.37181.371-5.372-5.3725.8365.836
Financing Cash Flow 28.47428.47494.66594.665-3.416-3.416-1.511-1.511-5.293-5.29359.82159.821556.32556.3281.37181.371-5.372-5.3725.8365.836
Other Information:
Effect Of Forex Changes On Cash -4.186-4.1869.5379.53718.26418.26424.61924.619-7.089-7.089-6.134-6.134-11.807-11.8070.5250.5255.1895.189-2.252-2.252
Net Change In Cash -157.234-157.234-57.8879.624-261.007-417.758-33.657-33.657-38.974-38.97487.36887.368547.208547.20810.83110.83173.50173.501-126.748-126.748
Cash At End Of Period -157.234-157.2341,400.20979.6241,458.0891,042.1331,459.89-33.657-38.9741,566.1781,605.15187.368547.208883.20833610.83173.501240.838167.337-126.748